Advertisement

Atopic Dermatitis

Disease State Hub

Resources
Research Summaries From the Journal
Insights
Q&As

FDA Alerts

Eczema
Eczema
FDA: Dupixent Approved for the Treatment of Eczema
03/28/2017
The US Food and Drug Administration has approved Dupixent for the treatment of moderate-to-severe eczema in adults.
03/28/2017
Eczema
Eczema
FDA: Dupixent Approved for the Treatment of Eczema
03/28/2017
The US Food and Drug Administration has approved Dupixent for the treatment of moderate-to-severe eczema in adults.
03/28/2017
FDA
FDA
FDA Approves New Treatment Option for Eczema
12/22/2016
The FDA has approved a new ointment for the treatment of mild-to-moderate eczema in patients aged 2 years and older.
12/22/2016
FDA
FDA
FDA Approves New Treatment Option for Eczema
12/22/2016
The FDA has approved a new ointment for the treatment of mild-to-moderate eczema in patients aged 2 years and older.
12/22/2016
Eczema
Eczema
FDA approves Pfizer's eczema ointment
12/15/2016
By Reuters Staff
12/15/2016
Eczema
Eczema
FDA approves Pfizer's eczema ointment
12/15/2016
By Reuters Staff
12/15/2016
FDA
FDA
FDA Approves New Treatment Option for Eczema
12/14/2016
The FDA has approved Eucrisa (crisaborole) ointment for the treatment of mild to moderate eczema (atopic dermatitis) in patients aged 2 years and older.
12/14/2016
FDA
FDA
FDA Approves New Treatment Option for Eczema
12/14/2016
The FDA has approved Eucrisa (crisaborole) ointment for the treatment of mild to moderate eczema (atopic dermatitis) in patients aged 2 years and older.
12/14/2016